National Framework Agreement for the Provision of Autism and ADHD Assessment Services
Contract Value:
GBP 15M -
Notice Type:
Contract Notice
Published Date:
08 January 2025
Closing Date:
07 February 2025
Location(s):
UK UNITED KINGDOM
UKD NORTH WEST (ENGLAND) (UK UNITED KINGDOM)
Description:
The Countess of Chester Hospital NHS Foundation Trust is establishing a Framework Agreement to provide assessment and diagnosis services for autism and ADHD for both adults and children, addressing increasing demand and long waiting lists.
National Framework Agreement for the Provision of Autism and ADHD Assessment Services. The Countess of Chester Hospital NHS Foundation Trust wishes to establish a Framework Agreement under the Health Care Services (Provider Selection Regime) Regulations 2023 (and as amended) (the PSR) for use by all Relevant Authorities (and any future successors to these organisations). “Relevant authority” is defined in section 12ZB(7) of the National Health Service Act 2006. It means a combined authority, an integrated care board, a local authority in England, NHS England, an NHS foundation trust or an NHS trust established under section 25 of that Act. For the avoidance of doubt, any successor bodies of any of the above entities shall be entitled to place Orders and shall be deemed Relevant Authorities for the purposes of this Framework Agreement. Demand for autism and ADHD assessment and diagnosis services has increased significantly in recent years, with waiting lists in some areas now years long. In order to address this backlog, many NHS organisations are outsourcing portions of this service to increase capacity, either on a short- or long-term basis. This Framework Agreement will provide a quick and compliant route to contract for these services. The overall aim of the Framework Agreement is to provide an assessment and diagnosis service for autism, ADHD and/or combined autism and ADHD for both adult and paediatric patients. For patients on the ADHD or combined pathway this may also include medication prescribing, titration and review. The term of the framework agreement will be 4 years.
This framework agreement will be formed of one Lot. Suppliers will be awarded to one of more of the below Services within that Lot: Adult Autism Spectrum Assessment and Diagnosis Children and Young People Autism Spectrum Assessment and Diagnosis Adult ADHD Assessment and Diagnosis Children and Young People ADHD Assessment and Diagnosis Adult Combined Autism Spectrum and ADHD Assessment and Diagnosis Children and Young People Combined Autism Spectrum and ADHD Assessment and Diagnosis ADHD Medication Prescribing, Titration and Review for Adults ADHD Medication Prescribing, Titration and Review for Children and Young People